Skip to main content

Table 2 Means, SEs, and differential treatment effects (Cohen’s d) of the CBT + M group versus the M-only group from baseline to one-year follow-up

From: One-year follow-up of the effectiveness and mediators of cognitive behavioural therapy among adults with attention-deficit/hyperactivity disorder: secondary outcomes of a randomised controlled trial

 

Baseline [mean (SE)]

One-year follow-up [mean (SE)]

Cohen’s d (95%CI)

CBT + M

M

CBT + M

M

ADHD-RS

25.8 (1.5)

23.5 (1.5)

18.3 (1.1)***

21.2 (1.1)

0.491 (0.088, 0.892)

SDS

41.7 (1.4)

41.6 (1.4)

37.5 (1.5)***

42.2 (1.5)

0.570 (0.164, 0.973)

WHOQoL-Psychological domain

46.2 (2.5)

46.8 (2.5)

53.1 (2.7)***

46.9 (2.7)

−0.433 (−0.827, −0.022)

ATQ

67.6 (3.3)

68.7 (3.3)

60.0 (3.8)*

69.3 (3.8)

0.387 (− 0.014, 0.786)

DAS

150.0 (4.7)

146.0 (4.7)

137.0 (4.5)***

144.0 (4.5)

0.395 (− 0.006, 0.794)

  1. ADHD-RS ADHD-Rating Scale: SDS Self-Rating Depression Scale: WHOQOL-BREF World Health Organization Quality of Life-Brief Version: CBT + M the CBT combined with medication group: M the medication-only group
  2. * p < 0.05; **: p < 0.01; ***: p < 0.001